Skip to main content
Smart Investors Daily
MD

NASDAQ · MDVL

MedAvail Holdings, Inc.

Healthcare · Medical - Pharmaceuticals

$1.80

Down-$1.37 (-43.22%)

Updated Aug 23, 2026, 3:40 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
2.91M
P/E ratio
-0.05
Dividend yield
0.00%
52-week range
$1.31 – $30.52
Volume
245.17K
Avg. volume
133.62K

Price performance

MDVL price history

1M range · 0 trading sessions · Daily adjusted prices

MDVL does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MDVL news

The latest Smart Investors Daily articles mentioning MDVL.

MDVL research

Overview

Company profile and research snapshot.

Company profile

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Nov 17, 2023

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 with the Securities and Exchange Commission.

GlobeNewswire Inc. · Aug 14, 2023

MedAvail Reports Second Quarter 2023 Financial Results

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.